INTRODUCTION
Over the past several years, it has become evident that polymerization of deoxyhemoglobin S within an eryth-rocyte can have profoundly deleterious effects on the cell's water content. The drastically reduced water content of irreversibly sickled cells (ISC)' (1, 2), presumed to have resulted from prolonged sickling, severely compromises the deformability of these cells, even when they are fully oxygenated (3) . In addition, because of the extreme dependence of hemoglobin S polymerization rates on hemoglobin concentration (4), even modest dehydration of discoid sickle cells would greatly increase their propensity to sickle at reduced oxygen tension. Noguchi and Schechter (5) have found that sickle cells contained some residual polymeric hemoglobin even at oxygen saturations >95%. Because mean arterial oxygen saturation values in sickle cell patients are <100%, they propose that a high hemoglobin S concentration leads to persistence of deoxyhemoglobin S polymers even in arterial blood, perhaps greatly shortening or eliminating the "delay time" for hemoglobin S gelation when cells encounter a low oxygen tension.
Because of the critical role of hemoglobin concentration in the sickling process, it has been proposed that a reduction of mean cell hemoglobin concentration (MCHC) of sickle cells below the normal value should provide an antisickling effect (6) . On the basis of such considerations, several investigators have initiated clinical studies in which sickle cell patients were treated with antidiuretic hormone and a low sodium (Na) diet, to reduce plasma osmolality and Na concentration, in hopes of producing a secondary reduc- ' Abbreviations used in this paper: BSKG, buffered saline containing potassium and glucose; DI, deformability index; DIDS, 4,4'-diisothiocyano-2,2'-stilbenedisulfonic acid; Hct, hematocrit; ISC, irreversibly sickled cells; MCHC, mean cell hemoglobin concentration. tion in MCHC (7) (8) (9) . Unfortunately, these trials have had only limited success, partly because of the difficulty in safely maintaining low plasma Na concentrations (8) 
METHODS
Erythrocytes were treated with Monensin under two separate sets of conditions: in plasma-free buffered solutions and in suspensions containing heated plasma. For treatment in the absence of plasma, erythrocytes were washed three times in buffered saline containing potassium and glucose (BSKG: 134 mM NaCl, 5 mM KCI, 8 .6 mM Na2HPO4, 1.4 mM Nati2PO4, and 11 mM glucose adjusted to 290-295 mosmol/ kg and pl 7.4) and resuspended to -5% hematocrit (Hct). A 2-mM stock solution of Na-Monensin (Calbiochem-Behring Corp., La Jolla, CA) in ethanol was then added after dilution in BSGK to give the desired final concentration.
(This resulted in addition of only 5 X 10-2 ,Ul of ethanol to 10 ml of cell suspension for a final Monensin concentration of 10 nM.) For treatment in the presence of plasma, heparinized blood samples were first centrifuged, and the plasma was heated to 56°C for 1 h to inactivate the lecithin-cholesterol acyltransferase enzyme, which causes echinocytosis during prolonged incubation (11) . While the plasma was being heated, the erythrocytes were washed in BSKG to remove residual plasma and the buffy coat. The washed cells were then recombined with a mixture of heated plasma and BSKG. A few experiments were performed in which cells were suspended in plasma alone. In these experiments, 10 mM glucose was added, and the cells were incubated under an atmosphere of 5% CO2 in air to maintain the pH.
The effect of Monensin on cellular ion and water content was monitored by measuring MCHC, intracellular Na and K content, and by analysis of cell density distribution on Stractan density gradients. MCHC was determined from spectrophotometric measurements of hemoglobin as the cyanomethemoglobin complex and from spun Hcts. Intracellular Na and K content were determined by flame photometric analysis of aliquoted erythrocytes washed in ice-cold, isotonic Tris-buffered magnesium chloride solution (10 mM Tris-HCl, pH 7.4).
Density analysis was performed by centrifuging the cells on disconitinutious gradients of Stractan II (St. Regis Paper Co., New York, NY) (12) . The gradients covered a density ranige from 1.065 to 1.139 g/ml, in increments of -0.009 g/ml. Quantitative evaluations of the cell density distribution were obtained by removing successive layers from the gradient with a Pasteur pipet and measuring their hemoglobin content.
Whole cell deformability was measured using the ektacytometer, a laser-diffraction couette viscometer (13) . This instrument provides a deformability index (DI) that is derived from photometric analysis of the laser diffraction image generated by the erythrocytes in the viscometer shear field. The DI value is proportional to the average ellipticity of a uniform population of deforming cells (13) and also provides a measure of the proportion of nondeforming cells in a mixture of deformable and nondeformable cells. We have previously shown that by measuring cell deformability in isotonic and hypotonic media, it is possible to determine whether cells are initially dehydrated or have a reduced surface area-to-volume ratio (13) . Dehydrated cells deform poorly in isotonic medium because of their elevated hemoglobin concentration and high intracellular viscosity. Their deformability is improved in hypotonic medium, in which they take up water and reduce their MCHC. In contrast, cells whose surface area-to-volume ratio is reduced (via either membrane loss or volume increase) show little or no impairment of their isotonic deformability, but show an abnormal reduction in hypotonic deformability. In the present studies, deformability was measured at 290 and 210 mosmol/kg to determine the hydration status of the samples.
Monensin has been shown to transport Na across the membrane by exchanging Na ions for protons (10) . Thus, to determine whether Monensin treatment had significantly disturbed the intracellular pH, we measured the pH of packed, freeze-thawed, Monensin-treated cells. In addition, because exchange of chloride for hydroxyl ions through the anion channel allows the erythrocyte to dissipate a pH gradient across the membrane (14), we performed experiments using the anion channel blocking agent, 4,4'-diisothiocyano-2,2'-stilbenedisulfonic acid (DIDS) (15) , to provide further understanding of Monensin's effects.
RESULTS
Treatment of sickle erythrocytes with surprisingly low concentrations of Monensin resulted in a dose-dependent increase in Na content ( Fig. 1 A) . A simultaneous decrease in intracellular K was also seen, but it was much smaller than the increase in Na, leading to a net increase in total cation content. The increase in total cation content entailed an increase in cell water, reflected in a Monensin dose-dependent reduction in MCHC ( Fig. 1 B) . For sickle cells, this Monensin-induced increase in cell ion and water content was accompanied by an increase in average cell deformability ( Fig. 1 B) . These experiments showed that for washed sickle cells, Monensin concentrations in the range of 10 to 20 nM gave the maximum improvement in cell deformability. Incubation This change was consistent with moderate cell swelling, resulting in a reduced surface area-to-volume ratio.
To provide additional understanding of Monensin's effect on cell water content, we subjected Monensintreated cells to density analysis on Stractan gradients. Fig. 2 shows the density distributions of samples of cells from a patient who had homozygous sickle cell disease (SS) All of these initial experiments had been performed with washed cells, but it was important to determine whether Monensin would be effective in the presence of plasma. It was found that suspending sickle cells in plasma, or in solutions containing a high proportion of plasma, increased -10-fold the Monensin concentration required to cause appreciable hydration. Fig.  3 shows a representative time course for changes in sickle cell deformability during such treatment. Monensin at 100 nM concentration caused a gradual improvement in cell deformability which was maintained for 24 h. Elevation of the Monensin concentration to 250 nM gave an initial improvement in deformability, but by the end of the 24-h incubation, cell deformability was lower than before Monensin treatment, an effect that was shown by hypotonic deforinability measurements to be the result of excessive water uptake. Monensin at 50 nM coneientration had no appreciable effect on cell deformability (data not shown).
The reduction in Monensin's effectiveness in the presence of plasma suggested that the drug could bind to plasma constituents and therefore was likely to distribute between plasma and erythrocytes. Thus (Table II) showed that increased cell Na and water content persisted for up to 8 h after removal of the drug. Density profiles of Monensin-treated cells had suggested that the entire sickle cell population responded more or less uniformly to Monensin. To test this possibility more directly, we isolated subpopulations of discoid and ISC-rich sickle cells and treated them separately with the drug. As summarized in Table III , both types of cells gained substantial amounts of Na while undergoing only slight changes in K content. Both showed substantial reductions in MCHC as a result of Na and water influx. Because of this reduction in MCHC, the ISC-rich cell populations improved their deformability. As previously observed with normal cells, the discoid cells showed virtually no change in isotonic deformability, implying that the degree of swelling they had undergone had not compromised their ability to deform in isotonic medium. The hypotonic deformability of both discoid cells and ISC was reduced at 50 nM Monensin after a 12-h incubation.
An interesting difference was noted in the response to Monensin of cells doubly heterozygous for hemoglobins S and C as compared to homozygous SS cells. As illustrated by the deformability curves in Fig. 4 , the initially depressed deformability curve of the SC cells became virtually identical to the curve for normal control cells after Monensin treatment. In contrast, deformability curves of homozygous SS cells whose initial deformability index (DI) was <80% of control were not completely transformed to the normal level at any Monensin concentration, although some improvement was always seen (the average increase in DI for seven such experiments was 24% of the initial value.) This difference in response to Monensin was mimicked by the response of SC and SS cell deformability to a reduction in suspending medium osmolal- not be the appropriate drug for this purpose. When e experiments in which cells were given to experimental animals, it becomes widely disnensin in the presence of DIDS agree tributed throughout body tissues and causes an eleonclusions about the mechanism of vation in heart rate and blood pressure at plasma con- (10) . In the presence of a suitable Na centrations in the micromolar range (19) . At present Monensin will exchange a Na ion for it is not clear whether erythrocyte cation content is Aonensin is added under physiological altered at drug concentrations in vivo below the ;radients across the erythrocyte mem-threshold for deleterious effects on other tissues. If into the cell in exchange for intracel-Monensin itself turns out to be too toxic to use, it might there were no means of relaxing the be possible to modify the drug by either pharmacologic t would build up from this exchange, or immunologic manipulations to give it a higher afn exchange would be limited. In the finity for the erythrocyte membrane, perhaps a selecvever, hydroxyl ions can exchange for tive affinity that could prolong its action and limit such 'ough the anion channel. Thus, while possible toxicity. ates the exchange of extracellular Na These experiments represent an early stage in the lular protons, the anion channel per-evaluation of a therapeutic approach to sickle cell dis-ease that is based on increasing membrane permeability for Na. Many questions remain to be addressed, but Monensin's potent effects on both MCHC and ISC deformability provide encouragement for this approach.
